Polymer therapeutics (e.g., polymer-drug conjugates, micellar structures, polymer-nucleic acid complexes, etc.) are macromolecular constructs containing bioactive agents that have shown enhanced delivery to solid tumors, sites of inflammation and infection, among other diseased locations [1].A challenge for clinical translation of some of these constructs is the limited accumulation at the target site.